THE Pharmacy Programs Administrator has extended transition arrangements for pharmacists delivering Medication Management Review (MMR) and Aged Care On-site Pharmacist (ACOP) services.
The MMR transition is extended to 31 Dec 2025, and the ACOP transition is extended to 30 Jun 2026.
This extension means pharmacists can continue delivering services using their existing Medication Review Numbers (MRNs) while they transition to new credentialing requirements.
The previous MMR transition deadline was 30 Jun, after which current MRNs were to become invalid (PD 19 Feb).
The Pharmaceutical Society of Australia (PSA) welcomed the announcement, with PSA Consultant Pharmacist Adviser Debbie Rigby noting the peak body's support for consultant pharmacists through the transition to new credentials.
"We've heard your concerns and have advocated for more time, particularly in ACOP roles," she said.
"I'm pleased there has been a time extension to complete the ACOP credential whilst continuing to implement this valuable service in aged care facilities."
Chair of the PSA's Consultant Pharmacists Community of Specialty Interest Deborah Hawthorne said the extension was a result of PSA's ongoing advocacy for consultant pharmacists.
"This decision provides much-needed certainty for consultant pharmacists, ensuring they can continue delivering critical patient care while completing their credentialing," Hawthorne said.
"We encourage all pharmacists to submit their evidence for recognition of prior learning (RPL) as soon as possible.
"We expect this will be the final extension, so it's your last real opportunity to make the most of the RPL pathway," she concluded.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 May 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 May 25
